The narrative explores the unsettling concept of a drug searching for a disease, highlighting the historical context of amphetamines and their powerful effects on dopamine. As researchers pivot from asthma to narcolepsy, the quest for a broader market leads to a collaboration with a pharmaceutical company. In a time of minimal regulation, doctors are given free samples to determine the drug's efficacy, raising questions about safety and ethical practices in the medical field.
